BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25579870)

  • 1. Evaluation of Pharmacologic Prevention of Pancreatitis After Endoscopic Retrograde Cholangiopancreatography: A Systematic Review.
    Kubiliun NM; Adams MA; Akshintala VS; Conte ML; Cote GA; Cotton PB; Dumonceau JM; Elta GH; Fogel EL; Freeman ML; Lehman GA; Naveed M; Romagnuolo J; Scheiman JM; Sherman S; Singh VK; Elmunzer BJ;
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1231-9; quiz e70-1. PubMed ID: 25579870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Combined Management with Nonsteroidal Anti-inflammatory Drugs for Prevention of Pancreatitis After Endoscopic Retrograde Cholangiography: a Bayesian Network Meta-analysis.
    Du F; Zhang Y; Yang X; Zhang L; Yuan W; Fan H; Ren L
    J Gastrointest Surg; 2022 Sep; 26(9):1982-1997. PubMed ID: 35680777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review for prevention and treatment.
    Pekgöz M
    World J Gastroenterol; 2019 Aug; 25(29):4019-4042. PubMed ID: 31413535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review with network meta-analysis: pharmacological prophylaxis against post-ERCP pancreatitis.
    Akshintala VS; Hutfless SM; Colantuoni E; Kim KJ; Khashab MA; Li T; Elmunzer BJ; Puhan MA; Sinha A; Kamal A; Lennon AM; Okolo PI; Palakurthy MK; Kalloo AN; Singh VK
    Aliment Pharmacol Ther; 2013 Dec; 38(11-12):1325-37. PubMed ID: 24138390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
    Lyu Y; Cheng Y; Wang B; Xu Y; Du W
    BMC Gastroenterol; 2018 Jul; 18(1):106. PubMed ID: 29973142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rectal nonsteroidal anti-inflammatory drugs administration is effective for the prevention of post-ERCP pancreatitis: An updated meta-analysis of randomized controlled trials.
    Yang C; Zhao Y; Li W; Zhu S; Yang H; Zhang Y; Liu X; Peng N; Fan P; Jin X
    Pancreatology; 2017; 17(5):681-688. PubMed ID: 28734720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis with a combination of pharmacological agents based on rectal non-steroidal anti-inflammatory drugs: A systematic review and network meta-analysis.
    Oh HC; Kang H; Park TY; Choi GJ; Lehman GA
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1403-1413. PubMed ID: 33068012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis.
    Akbar A; Abu Dayyeh BK; Baron TH; Wang Z; Altayar O; Murad MH
    Clin Gastroenterol Hepatol; 2013 Jul; 11(7):778-83. PubMed ID: 23376320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsteroidal Anti-inflammatory Drugs for Endoscopic Retrograde Cholangiopancreatography Postoperative Pancreatitis Prevention: a Systematic Review and Meta-analysis.
    Liu L; Li C; Huang Y; Jin H
    J Gastrointest Surg; 2019 Oct; 23(10):1991-2001. PubMed ID: 30251071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitroglycerin combined with NSAIDs for prevention of post-ERCP pancreatitis: A meta-analysis of prospective, randomized, controlled trials.
    Zhang X; Zhang JM; Wei W; Lin H
    Medicine (Baltimore); 2024 Jul; 103(27):e38764. PubMed ID: 38968498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsteroidal anti-inflammatory drugs reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis.
    Li L; Han Z; Yuan H; Zhang G; Jia Y; He C
    J Hepatobiliary Pancreat Sci; 2017 Sep; 24(9):520-529. PubMed ID: 28681997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis.
    Elmunzer BJ; Waljee AK; Elta GH; Taylor JR; Fehmi SM; Higgins PD
    Gut; 2008 Sep; 57(9):1262-7. PubMed ID: 18375470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic and pharmacological treatment for prophylaxis against postendoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis and systematic review.
    Vadalà di Prampero SF; Faleschini G; Panic N; Bulajic M
    Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1415-1424. PubMed ID: 27580214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Elmunzer BJ
    Dig Endosc; 2017 Nov; 29(7):749-757. PubMed ID: 28636774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis on the role of rectal diclofenac and indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Sethi S; Sethi N; Wadhwa V; Garud S; Brown A
    Pancreas; 2014 Mar; 43(2):190-7. PubMed ID: 24518496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rectal NSAIDs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in unselected patients: Systematic review and meta-analysis.
    Shen C; Shi Y; Liang T; Su P
    Dig Endosc; 2017 May; 29(3):281-290. PubMed ID: 28112441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-ERCP pancreatitis.
    Arata S; Takada T; Hirata K; Yoshida M; Mayumi T; Hirota M; Yokoe M; Hirota M; Kiriyama S; Sekimoto M; Amano H; Wada K; Kimura Y; Gabata T; Takeda K; Kataoka K; Ito T; Tanaka M
    J Hepatobiliary Pancreat Sci; 2010 Jan; 17(1):70-8. PubMed ID: 20012323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Affecting the Efficacy of Nonsteroidal Anti-inflammatory Drugs in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Systematic Review and Meta-analysis.
    Rustagi T; Njei B
    Pancreas; 2015 Aug; 44(6):859-67. PubMed ID: 26168316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Multicenter, Prospective, Randomized Controlled Trial Evaluating the Efficacy of Rectal Diclofenac and Sublingual Nitroglycerin as a Combined Prophylactic Treatment for Post-ERCP Pancreatitis.
    Tomoda T; Kato H; Mizukawa S; Muro S; Akimoto Y; Uchida D; Matsumoto K; Yamamoto N; Horiguchi S; Tsutsumi K; Okada H
    Acta Med Okayama; 2016 Octoaber; 70(5):405-408. PubMed ID: 27777436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive effect of ulinastatin and gabexate mesylate on post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Zhang ZF; Yang N; Zhao G; Zhu L; Zhu Y; Wang LX
    Chin Med J (Engl); 2010 Sep; 123(18):2600-6. PubMed ID: 21034635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.